Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-93.94	27.30	450.56
Graham Fair Price	-37.07	2479.25	3939.72
PEG	112.43	-0.05	0.02
Price/Book	-22.69	0.39	0.51
Price/Cash Flow	9.83	-2.94	2.68
Prices/Earnings	103.27	6.80	-3.35
Price/Sales	-35.32	0.36	0.56
Price/FCF	9.83	-2.94	2.68
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	26.02	0.16	0.13
Operating Margin	165.26	0.05	-0.02
ROA	-64.57	< 0.005	-0.01
ROE	-0.04	0.01	-61.96
ROIC	< 0.005	0.01	109.23
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.10	-0.14	-28.81
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-1.12	4.24	277.47
EPS QOQ	-1.45	1.39	-4.31
FCF QOQ	-0.17	-1.72	-909.37
Revenue QOQ	-0.39	0.22	-43.90
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	107.86	104.34	-3.27
Days Sales Outstanding (DSO)	24.55	28.32	15.37
Inventory Turnover	0.83	0.86	3.38
Debt/Capitalization	0.62	0.64	2.82
Quick Ratio	0.39	0.33	-13.82
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	4274.48	4361.57	2.04
Cash	1241.09	1390.03	12.00
Capex	-101.29	-100.76	0.52
Free Cash Flow	807.07	-579.69	-28.17
Revenue	3828.13	4669.33	21.97
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.09	0.90	-17.90
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	341.93	22.22	-93.50
Naive Interpretation	Member

06 - Financial Health · Bad

Rating